UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening

PloS one, 2011-10, Vol.6 (10), p.e26169

2011

Volltextzugriff (PDF)

Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening

ACS chemical biology, 2011-06, Vol.6 (6), p.628-635

2011

Volltextzugriff (PDF)

Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1

Journal of medicinal chemistry, 2005-12, Vol.48 (25), p.8045-8054

2005

Volltextzugriff (PDF)

Perspectives on phenotypic screening−Screen Design and Assay Technology Special Interest Group

SLAS discovery, 2024-03, Vol.29 (2), p.100146-100146, Article 100146

2024

Volltextzugriff (PDF)

Targeted drug discovery for pediatric leukemia

Frontiers in oncology, 2013-01, Vol.3, p.170

2013

Volltextzugriff (PDF)

Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay

Antimicrobial Agents and Chemotherapy, 2010-09, Vol.54 (9), p.3597-3604

2010

Volltextzugriff (PDF)

Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture

Analytical biochemistry, 2017-10, Vol.535, p.25-34

2017

Volltextzugriff (PDF)

Kinetic Characterization and Molecular Docking of a Novel, Potent, and Selective Slow-Binding Inhibitor of Human Cathepsin L

Molecular pharmacology, 2008-07, Vol.74 (1), p.34-41

2008

Volltextzugriff (PDF)

Discriminating High-Value Hits from PAINS

Assay and drug development technologies, 2016-04, Vol.14 (3), p.157-157

Napper, Andrew D

2016

Volltextzugriff (PDF)

Perspectives in ASSAY and Drug Development Technologies

Assay and drug development technologies, 2015-06, Vol.13 (5), p.241-241

Napper, Andrew D

2015

Volltextzugriff (PDF)

A new chapter for ASSAY and drug development technologies

Assay and drug development technologies, 2015-02, Vol.13 (1), p.1-1

Napper, Andrew D

2015

Volltextzugriff (PDF)

Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms

Journal of antimicrobial chemotherapy, 2011-04, Vol.66 (4), p.820-826

2011

Volltextzugriff (PDF)

Interview with Jonathan Baell, PhD

Assay and drug development technologies, 2016-04, Vol.14 (3), p.164-167

Napper, Andrew D

2016

Volltextzugriff (PDF)

Implementation of a High-Throughput Pilot Screen in Peptide Hydrogel-Based Three-Dimensional Cell Cultures

SLAS discovery, 2019-08, Vol.24 (7), p.714-723

2019

Volltextzugriff (PDF)

Interview with Haian Fu, PhD

Assay and drug development technologies, 2015-06, Vol.13 (5), p.249-253

2015

Volltextzugriff (PDF)

Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: The confounding effects of DTT and cysteine in biological assays

Bioorganic & medicinal chemistry letters, 2007-09, Vol.17 (17), p.4761-4766

2007

Volltextzugriff (PDF)

A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes

Assay and drug development technologies, 2014-06, Vol.12 (5), p.258-271

2014

Volltextzugriff (PDF)

Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy- d- xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)

Bioorganic & medicinal chemistry, 2010-01, Vol.18 (2), p.896-908

2010

Volltextzugriff (PDF)

A Special Focus on Drug Repurposing, Rescue, and Repositioning

Assay and drug development technologies, 2015-07, Vol.13 (6), p.293-293

2015

Volltextzugriff (PDF)

Discovery of chemical modulators of a conserved translational control pathway by parallel screening in yeast

Assay and drug development technologies, 2009-10, Vol.7 (5), p.479-494

2009

Volltextzugriff (PDF)

Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology

Assay and drug development technologies, 2013-05, Vol.11 (4), p.253-268

2013

Volltextzugriff (PDF)

Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient

Frontiers in oncology, 2017-04, Vol.7, p.42-42

2017

Volltextzugriff (PDF)

Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1

Journal of medicinal chemistry, 2007-03, Vol.50 (5), p.1086-1086

2007

Volltextzugriff (PDF)

An interview with Andrew D. Napper, Ph.D. Interview

Assay and drug development technologies, 2008-10, Vol.6 (5), p.611

Napper, Andrew D

2008

Volltextzugriff (PDF)

Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibility

Assay and drug development technologies, 2014-10, Vol.12 (8), p.443-451

2014

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(63)
Buchkapitel
(1)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening

Identification of Specific Inhibitors of Human RAD51 Recombinase Using High-Throughput Screening

Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1

Perspectives on phenotypic screening−Screen Design and Assay Technology Special Interest Group

Targeted drug discovery for pediatric leukemia

Discovery of Potent Small-Molecule Inhibitors of Multidrug-Resistant Plasmodium falciparum Using a Novel Miniaturized High-Throughput Luciferase-Based Assay

Beta-hairpin hydrogels as scaffolds for high-throughput drug discovery in three-dimensional cell culture

Kinetic Characterization and Molecular Docking of a Novel, Potent, and Selective Slow-Binding Inhibitor of Human Cathepsin L

Discriminating High-Value Hits from PAINS

Perspectives in ASSAY and Drug Development Technologies

A new chapter for ASSAY and drug development technologies

Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms

Interview with Jonathan Baell, PhD

Implementation of a High-Throughput Pilot Screen in Peptide Hydrogel-Based Three-Dimensional Cell Cultures

Interview with Haian Fu, PhD

Identification and characterization of 3-substituted pyrazolyl esters as alternate substrates for cathepsin B: The confounding effects of DTT and cysteine in biological assays

A sensitive luminescent assay for the histone methyltransferase NSD1 and other SAM-dependent enzymes

Identification of triazinoindol-benzimidazolones as nanomolar inhibitors of the Mycobacterium tuberculosis enzyme TDP-6-deoxy- d- xylo-4-hexopyranosid-4-ulose 3,5-epimerase (RmlC)

A Special Focus on Drug Repurposing, Rescue, and Repositioning

Discovery of chemical modulators of a conserved translational control pathway by parallel screening in yeast

Development of a high-throughput screening-compatible assay for the discovery of inhibitors of the AF4-AF9 interaction using AlphaScreen technology

Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient

Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1

An interview with Andrew D. Napper, Ph.D. Interview

Controversies in ASSAY and drug development technologies: a focus on assessing irreproducibility

Suchergebnisse filtern